Pages that link to "Q71058625"

The following pages link to Arrest of beta-amyloid fibril formation by a pentapeptide ligand (Q71058625):

Displaying 50 items.

• An atomic model for the pleated beta-sheet structure of abeta amyloid protofilaments (Q24170232) ‎ (← links)
• Effect of N-homocysteinylation on physicochemical and cytotoxic properties of amyloid β-peptide (Q24300725) ‎ (← links)
• Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein/NAC precursor that bind Abeta and NAC (Q24530132) ‎ (← links)
• Molecular basis for insulin fibril assembly (Q24657505) ‎ (← links)
• The Alzheimer's peptides Abeta40 and 42 adopt distinct conformations in water: a combined MD / NMR study (Q24683781) ‎ (← links)
• Sequence determinants of protein aggregation: tools to increase protein solubility (Q24795353) ‎ (← links)
• The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer's Disease (Q26768487) ‎ (← links)
• Stabilization of a  -hairpin in monomeric Alzheimer's amyloid-  peptide inhibits amyloid formation (Q27650192) ‎ (← links)
• Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation (Q27670453) ‎ (← links)
• Towards a Pharmacophore for Amyloid (Q27670496) ‎ (← links)
• Molecular Basis of Substrate Recognition and Degradation by Human Presequence Protease (Q27684349) ‎ (← links)
• A Fibril-Like Assembly of Oligomers of a Peptide Derived from β-Amyloid (Q27684839) ‎ (← links)
• In vitro fibrillogenesis of the amyloid beta 1-42 peptide: cholesterol potentiation and aspirin inhibition (Q28194417) ‎ (← links)
• Common binding sites for beta-amyloid fibrils and fibroblast growth factor-2 in heparan sulfate from human cerebral cortex (Q28374326) ‎ (← links)
• A foldamer-dendrimer conjugate neutralizes synaptotoxic β-amyloid oligomers (Q28481656) ‎ (← links)
• Computational design of new Peptide inhibitors for amyloid Beta (aβ) aggregation in Alzheimer's disease: application of a novel methodology (Q28533731) ‎ (← links)
• Molecular investigations of protriptyline as a multi-target directed ligand in Alzheimer's disease (Q28542431) ‎ (← links)
• Drug Development in Conformational Diseases: A Novel Family of Chemical Chaperones that Bind and Stabilise Several Polymorphic Amyloid Structures (Q28547692) ‎ (← links)
• De novo design of α,β-didehydrophenylalanine containing peptides: From models to applications (Q30395902) ‎ (← links)
• Drugs of abuse that mediate advanced glycation end product formation: a chemical link to disease pathology (Q30434143) ‎ (← links)
• Insulysin hydrolyzes amyloid beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques. (Q30974615) ‎ (← links)
• Cyclic modular beta-sheets (Q33273424) ‎ (← links)
• Molecules that target beta-amyloid (Q33303421) ‎ (← links)
• Peptide ligand screening of alpha-synuclein aggregation modulators by in silico panning (Q33305729) ‎ (← links)
• Structural elements regulating amyloidogenesis: a cholinesterase model system (Q33324410) ‎ (← links)
• A resorcinarene for inhibition of Aβ fibrillation (Q33583650) ‎ (← links)
• Plaque busters: strategies to inhibit amyloid formation in Alzheimer's disease (Q33702171) ‎ (← links)
• Molecular basis for amyloid fibril formation and stability (Q33722932) ‎ (← links)
• Quantitative structure-activity relationship analysis of β-amyloid aggregation inhibitors (Q33774384) ‎ (← links)
• Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer's disease (Q33809078) ‎ (← links)
• Unfolding of the amyloid β-peptide central helix: mechanistic insights from molecular dynamics simulations (Q33847868) ‎ (← links)
• Aromaticity and amyloid formation: effect of π-electron distribution and aryl substituent geometry on the self-assembly of peptides derived from hIAPP(22-29). (Q33852711) ‎ (← links)
• Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies (Q33893017) ‎ (← links)
• Rationally designed peptoids modulate aggregation of amyloid-beta 40. (Q33918190) ‎ (← links)
• Transthyretin-derived peptides as β-amyloid inhibitors (Q33918213) ‎ (← links)
• Substoichiometric inhibition of Abeta(1-40) aggregation by a tandem Abeta(40-1-Gly8-1-40) peptide (Q33965466) ‎ (← links)
• Oligomerizaiton and fibril asssembly of the amyloid-beta protein. (Q33971276) ‎ (← links)
• Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization (Q33971304) ‎ (← links)
• Mechanistic investigation of the inhibition of Abeta42 assembly and neurotoxicity by Abeta42 C-terminal fragments (Q34029566) ‎ (← links)
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation (Q34088689) ‎ (← links)
• Peptides for therapy and diagnosis of Alzheimer's disease (Q34124260) ‎ (← links)
• Animal models of Alzheimer's disease and evaluation of anti-dementia drugs (Q34126136) ‎ (← links)
• The amyloid stretch hypothesis: recruiting proteins toward the dark side (Q34133256) ‎ (← links)
• Effects of ligands on unfolding of the amyloid β-peptide central helix: mechanistic insights from molecular dynamics simulations (Q34146163) ‎ (← links)
• Characterization of the Interaction of β-Amyloid with Transthyretin Monomers and Tetramers (Q34146589) ‎ (← links)
• Glycation of the amyloid beta-protein by a nicotine metabolite: a fortuitous chemical dynamic between smoking and Alzheimer's disease (Q34207086) ‎ (← links)
• Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria (Q34282165) ‎ (← links)
• Altering APP proteolysis: increasing sAPPalpha production by targeting dimerization of the APP ectodomain (Q34328562) ‎ (← links)
• Structure of core domain of fibril-forming PHF/Tau fragments. (Q34354306) ‎ (← links)
• Recent Development of Bifunctional Small Molecules to Study Metal-Amyloid-β Species in Alzheimer's Disease (Q34416770) ‎ (← links)